LUNG CANCER METASTATIC
Clinical trials for LUNG CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER METASTATIC trials appear
Sign up with your email to follow new studies for LUNG CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung cancer brain metastasis study halted after just 3 patients
Disease control TerminatedThis study aimed to see if adding the drug pembrolizumab to chemotherapy could help control lung cancer that has spread to the brain without causing new symptoms. It was designed for people with untreated, asymptomatic brain metastases and no specific genetic mutations. However, …
Matched conditions: LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: John L. Villano, MD, PhD • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New pill plus immunotherapy shows promise for tough lung cancer
Disease control TerminatedThis study tested a new pill (SLC-391) combined with an immunotherapy drug (pembrolizumab) in people with advanced non-small cell lung cancer. The goal was to find a safe dose and see if the combo could shrink tumors or stop them from growing. The trial was stopped early, but res…
Matched conditions: LUNG CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: SignalChem Lifesciences Corporation • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Could a cholesterol drug boost lung cancer immunotherapy?
Disease control TerminatedThis study tested whether adding evolocumab (a cholesterol-lowering drug) to standard immunotherapy (nivolumab and ipilimumab) is safe and helps the immune system fight advanced non-small cell lung cancer. It involved 19 people with newly diagnosed metastatic lung cancer who had …
Matched conditions: LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Eziafa Oduah, MD, PhD, MPH • Aim: Disease control
Last updated May 11, 2026 20:39 UTC